Literature DB >> 1911127

Contribution of experimental studies on the nutritional management of children with chronic renal failure.

C Kleinknecht1, D Laouari, M Burtin, S Maniar, C Jurkovitz.   

Abstract

A few of the many reports of experimental chronic renal failure have been summarized. Anorexia and food selection have been studied in experimental uremia and the findings are comparable with those observed in uraemic children. The optimal dietary protein content for growth is close to the minimal requirement for "optimal" growth. Protein excess leads to growth retardation and renal deterioration in uraemic rats, at least with the commonly used dry diets. The increased water requirement may be more critical for growth than the blood urea level or acidosis, although this requires further investigation. Reduction of the dietary protein by 50% and supplementation with essential amino acids (EAA) results in growth similar to that of the 100% protein diet. There is no growth improvement despite low blood urea levels, but the renal parenchymal is preserved. Supplementation with nitrogen-free analogues is more frequently associated with defective growth; the optimal mixture remains to be defined, and to date, when nutrition is identical, nitrogen-free analogues offer no benefit for renal preservation compared with EAA. Sucrose-rich diets have adverse effects on uraemia. These effects are associated with fructose intolerance and with reduced energy storage in the liver. The precise metabolic alteration remains to be defined.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911127     DOI: 10.1007/bf01453687

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  20 in total

1.  The amino acid composition and the nutritive value of proteins. I. Essential amino acid requirements of the growing rat.

Authors:  P B Rao; V C Metta; B C Johnson
Journal:  J Nutr       Date:  1959-12       Impact factor: 4.798

2.  Growth, free plasma and muscle amino-acids in uraemic rats fed various low-protein diets.

Authors:  D Laouari; G Jean; C Kleinknecht; M Broyer
Journal:  Pediatr Nephrol       Date:  1991-05       Impact factor: 3.714

3.  Optimal dietary substitution of racemic ketoanalogues for isoleucine in growing normal and uremic rats.

Authors:  D Laouari; P R Parvy; M Burtin; C Kleinknecht; M Broyer
Journal:  Am J Clin Nutr       Date:  1990-06       Impact factor: 7.045

Review 4.  Growth and appetite in chronic renal failure. Role of different protein diets.

Authors:  D Laouari; C Kleinknecht; M Burtin; C Dodu
Journal:  Contrib Nephrol       Date:  1988       Impact factor: 1.580

Review 5.  Growth in renal failure.

Authors:  O Mehls; E Ritz; G Gilli; W Kreusser
Journal:  Nephron       Date:  1978       Impact factor: 2.847

6.  Substitution of five essential amino acids by their alpha-keto analogues in the diet of rats.

Authors:  K W Chow; M Walser
Journal:  J Nutr       Date:  1974-09       Impact factor: 4.798

7.  1980 Revised Recommended Dietary Allowances.

Authors: 
Journal:  J Am Diet Assoc       Date:  1979-12

8.  Prolonged renal survival and stunting, with protein-deficient diets in experimental uremia. Reversal of these effects by addition of essential amino acids.

Authors:  I Salusky; C Kleinknecht; M Broyer; M C Gubler
Journal:  J Lab Clin Med       Date:  1981-01

9.  Efficiency of substitution of 2-ketoisocaproic acid and 2-ketoisovaleric acid in the diet of normal and uremic growing rats.

Authors:  D Laouari; P P Kamoun; F Rocchiccioli; C Dodu; C Kleinknecht; M Broyer
Journal:  Am J Clin Nutr       Date:  1986-12       Impact factor: 7.045

10.  The effect of keto-analogues of essential amino acids in severe chronic uremia.

Authors:  M Walser; A W Coulter; S Dighe; F R Crantz
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

View more
  1 in total

1.  Nutritional status of children with moderate chronic renal failure.

Authors:  G Orejas; F Santos; S Málaga; C Rey; A Cobo; M Simarro
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.